SCHEMBL17295367

SCHEMBL17295367

O=C1C(=Cc2ccc3[nH]ccc3c2)SC(=NCc2ccccc2)N1c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 9/20 0.44
▸ S1PR3 Q99500 9/20 0.44
▸ MAPT P10636 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ FAAH O00519 1/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GAA P10253 4/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ ATM Q13315 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ MGAM O43451 3/20 0.42
▸ SI P14410 3/20 0.42
▸ MGAM2 Q2M2H8 3/20 0.42
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29726499 1.00 S1PR1 (0.44) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295365 1.00 S1PR1 (0.44) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295343 0.96 S1PR1 (0.47) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295344 0.96 S1PR1 (0.47) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295542 0.85 S1PR1 (0.54) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295541 0.85 S1PR1 (0.54) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295410 0.84 S1PR1 (0.52) S1PR1S1PR3ALDH1A1FAAHMEN1
SCHEMBL17295412 0.84 S1PR1 (0.52) S1PR1S1PR3ALDH1A1FAAHMEN1
SCHEMBL17295428 0.84 FAAH (0.44) S1PR1S1PR3MAPTALDH1A1HPGD
SCHEMBL17295426 0.84 FAAH (0.44) S1PR1S1PR3MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback